Terpene Control in Scaleable Cannabinoids Medicinal Formulations
US-2024390319-A1 · Nov 28, 2024 · US
US2020360455A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020360455-A1 |
| Application number | US-201916965780-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 31, 2019 |
| Priority date | Feb 1, 2018 |
| Publication date | Nov 19, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The nutmeg extract of the present invention contains a high quantity of ligand-based compounds and exhibits, when taken, very excellent effects of improving athletic ability, improving endurance and improving muscular strength, and thus is effective for treating sarcopenia and can be effectively used in medical supplies, food and the like for improving physical strength or athletic ability.
Opening claim text (preview).
1 - 12 . (canceled) 13 . A method for improving physical strength or athletic ability or improving muscle function or increasing the amount of muscle in a subject, the method comprising administering an effective amount of a composition comprising a nutmeg extract as an active ingredient to the subject in need thereof. 14 . (canceled) 15 . A method for treating or improving sarcopenia in a subject, the method comprising administering an effective amount of a composition comprising a nutmeg extract as an active ingredient to the subject in need thereof. 16 . (canceled) 17 . (canceled) 18 . (canceled) 19 . An anti-fatigue method, the method comprising administering an effective amount of a composition comprising a nutmeg extract as an active ingredient to a subject in need thereof. 20 . The method of claim 13 , wherein the nutmeg extract is an extract obtained with one or more solvents selected from the group consisting of water, alcohol having 1 to 6 carbon atoms, acetone, ether, benzene, chloroform, ethyl acetate, methylene chloride, hexane, cyclohexane, petroleum ether, subcritical fluid and supercritical fluid. 21 . The method of claim 13 , wherein the improvement in athletic ability is to increase muscle endurance or strengthen muscle strength. 22 . The method of claim 13 , wherein the nutmeg extract further comprises a property that increases the level of glycogen at a cellular level. 23 . The method of claim 13 , wherein the composition is a pharmaceutical composition, a food composition, or a feed additive. 24 . The method of claim 13 , wherein the method is for a middle-aged or older individual. 25 . The method of claim 15 , wherein the composition is a pharmaceutical composition or a food composition. 26 . The method of claim 19 , wherein the composition is a pharmaceutical composition or a food composition.
Organic compounds · CPC title
Magnoliopsida (dicotyledons) · CPC title
Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction · CPC title
using mixed solvents, e.g. 70% EtOH · CPC title
Extraction with lipophilic solvents, e.g. Hexane or petrol ether · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.